Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 1
2019 1
2020 2
2021 4
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

6 results

Results by year

Filters applied: . Clear all
Proximity search should include two or more words. Proximity operator ignored :~0
Page 1
Fibroblastic and myofibroblastic tumors of children: new genetic entities and new ancillary testing.
Parham DM. Parham DM. F1000Res. 2018 Dec 20;7:F1000 Faculty Rev-1963. doi: 10.12688/f1000research.16236.1. eCollection 2018. F1000Res. 2018. PMID: 30613391 Free PMC article. Review.
Included will be newer information on fibrous hamartoma of infancy, infantile myofibromatosis, lipofibromatosis, and infantile fibrosarcoma and tumors resembling it, including primitive myxoid mesenchymal tumor of infancy and new genetic entities. ...
Included will be newer information on fibrous hamartoma of infancy, infantile myofibromatosis, lipofibromatosis, and infantile fibros …
Gynecology and Oncology Fetal Myofibromatosis: A Challenge for Prenatal Diagnosis Mini Review of the English Literature.
Pekar-Zlotin M, Levinsohn-Tavor O, Livneh A, Sher O, Melcer Y, Maymon R. Pekar-Zlotin M, et al. Obstet Gynecol Surv. 2019 Oct;74(10):607-610. doi: 10.1097/OGX.0000000000000717. Obstet Gynecol Surv. 2019. PMID: 31670833 Review.
IMPORTANCE: Infantile myofibromatosis (IM) is a benign neoplasm with a reported incidence of 1:150,000. ...
IMPORTANCE: Infantile myofibromatosis (IM) is a benign neoplasm with a reported incidence of 1:150,000. ...
Diverse presentation and tailored treatment of infantile myofibromatosis: A single-center experience.
Manisterski M, Benish M, Levin D, Shiran SI, Sher O, Gortzak Y, Elhasid R. Manisterski M, et al. Pediatr Blood Cancer. 2021 Feb;68(2):e28769. doi: 10.1002/pbc.28769. Epub 2020 Oct 16. Pediatr Blood Cancer. 2021. PMID: 33063933
BACKGROUND: Infantile myofibromatosis (IM) is a rare benign fibrous tumor with diverse clinical presentations and treatments, such as watchful waiting, surgical excision, and low-dose chemotherapy. ...
BACKGROUND: Infantile myofibromatosis (IM) is a rare benign fibrous tumor with diverse clinical presentations and treatments, such as …
Genetic testing and surveillance in infantile myofibromatosis: a report from the SIOPE Host Genome Working Group.
Hettmer S, Dachy G, Seitz G, Agaimy A, Duncan C, Jongmans M, Hirsch S, Kventsel I, Kordes U, de Krijger RR, Metzler M, Michaeli O, Nemes K, Poluha A, Ripperger T, Russo A, Smetsers S, Sparber-Sauer M, Stutz E, Bourdeaut F, Kratz CP, Demoulin JB. Hettmer S, et al. Fam Cancer. 2021 Oct;20(4):327-336. doi: 10.1007/s10689-020-00204-2. Epub 2020 Sep 5. Fam Cancer. 2021. PMID: 32888134 Free PMC article.
Infantile myofibromatosis (IM), which is typically diagnosed in young children, comprises a wide clinical spectrum ranging from inconspicuous solitary soft tissue nodules to multiple disseminated tumors resulting in life-threatening complications. ...
Infantile myofibromatosis (IM), which is typically diagnosed in young children, comprises a wide clinical spectrum ranging from incon …
Proportion of children with cancer that have an indication for genetic counseling and testing based on the cancer type irrespective of other features.
Nguyen TMK, Behnert A, Pietsch T, Vokuhl C, Kratz CP. Nguyen TMK, et al. Fam Cancer. 2021 Oct;20(4):273-277. doi: 10.1007/s10689-021-00234-4. Epub 2021 Feb 26. Fam Cancer. 2021. PMID: 33634344 Free PMC article.
The most common diagnoses were myelodysplastic syndrome and juvenile myelomonocytic leukemia, retinoblastoma, malignant peripheral nerve sheath tumor, infantile myofibromatosis, medulloblastoma(SHH), rhabdoid tumor as well as atypical teratoid/rhabdoid tumor. ...
The most common diagnoses were myelodysplastic syndrome and juvenile myelomonocytic leukemia, retinoblastoma, malignant peripheral nerve she …
Infantile myofibromatosis: Excellent prognosis but also rare fatal progressive disease. Treatment results of five Cooperative Weichteilsarkom Studiengruppe (CWS) trials and one registry.
Sparber-Sauer M, Vokuhl C, Seitz G, Sorg B, Tobias M, von Kalle T, Münter M, Bielack SS, Ladenstein R, Ljungman G, Niggli F, Frühwald M, Loff S, Klingebiel T, Koscielniak E. Sparber-Sauer M, et al. Pediatr Blood Cancer. 2022 Mar;69(3):e29403. doi: 10.1002/pbc.29403. Epub 2021 Oct 11. Pediatr Blood Cancer. 2022. PMID: 34636137
BACKGROUND: Infantile myofibromatosis (IM) is a rare benign soft tissue tumor and often a self-limiting disease but rarely includes life-threatening complications. ...
BACKGROUND: Infantile myofibromatosis (IM) is a rare benign soft tissue tumor and often a self-limiting disease but rarely includes l …